A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

Clinical trial NCT05421858 · RECRUITING

Trial details

NCT number: NCT05421858
Sponsor: Basilea Pharmaceutica
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Candidemia Candidiasis, Invasive

Start date: 2024-12-11
Primary completion: 2028-01-30
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.